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Abstract
Background: Analyzing the integration profile of retroviral vectors is a vital step in determining their potential
genotoxic effects and developing safer vectors for therapeutic use. Identifying retroviral vector integration sites is
also important for retroviral mutagenesis screens.
Results: We developed VISA, a vector integration site analysis server, to analyze next-generation sequencing data
for retroviral vector integration sites. Sequence reads that contain a provirus are mapped to the human genome,
sequence reads that cannot be localized to a unique location in the genome are filtered out, and then unique
retroviral vector integration sites are determined based on the alignment scores of the remaining sequence reads.
Conclusions: VISA offers a simple web interface to upload sequence files and results are returned in a concise
tabular format to allow rapid analysis of retroviral vector integration sites.
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Background
Retroviral vector mediated gene therapy has enormous
potential for treating genetic disorders [1] and infectious
diseases [2]. Unfortunately, vector integration can lead
to the dysregulation of nearby genes, commonly referred
to as genotoxicity [3]. Prime examples of the effects of
genotoxicity include two X-linked severe combined im-
munodeficiency (SCID-X1) patients who were treated
with a gammaretroviral vector in a clinical trial and de-
veloped lymphoproliferative leukemias a few years later
[4]. It was discovered that transduced cells from the pa-
tients contained integration sites near the LMO2 gene
and that there was aberrant expression of LMO2. Taken
together, this suggested that vector-mediated dysregula-
tion of LMO2 led to clonal dominance and the develop-
ment of leukemia in the patients. This study highlights
the importance of evaluating the safety of retroviral
vectors.
Identifying retroviral vector integration sites (RISs) is
critical to assess genotoxicity in gene therapy clinical trials
and to develop improved vectors in preclinical studies.
Another use of RIS mapping is for retroviral mutagenesis
screens. In these screens genes identified near the provirus
are candidate cancer initiation or progression genes [5].
Retroviral proviruses act as molecular tags, enabling
the detection of RISs via methods such as linear
amplification-mediated (LAM)-PCR and other next gener-
ation sequencing (NGS) methods [6, 7]. NGS can generate
millions of sequence reads and an individual RIS can be
represented multiple times in NGS data, making the iden-
tification and annotation of RISs challenging. We present
a Vector Integration Site Analysis (VISA) server, a tool
that allows investigators with limited bioinformatics ex-
perience to rapidly analyze large NGS datasets for RISs.
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Implementation
Identify LTR-chromosome junctions and generate query
sequences
Sequencing DNA samples from retroviral vector integra-
tion studies with a long terminal repeat (LTR) primer
produces sequence reads with LTR-chromosome junctions,
with the LTR sequence flanking the 5′ end of the chromo-
some/genomic sequence. Methods such as LAM-PCR will
additionally result in a linker cassette (LC) sequence flank-
ing the 3′ end of the genomic sequence. VISA uses a Perl
substring matching strategy to detect and remove these
non-genomic sequences to generate the queries for
alignment (see Additional file 1 section ‘Trimming non-
genomic portions of the sequence reads’ for details). VISA
accepts multiple sequence reads in a single FASTA for-
matted file as input. Each sequence is trimmed with the
following steps: (1) The vector LTR sequence is searched
for in the sequence read. If the LTR sequence is found, the
query begins downstream of the LTR position. (2, optional)
The LC sequence is searched for in the query. If the LC
sequence is found, the query is truncated upstream of the
LC position. (3) If the sequence read contains a valid
query, the query will be truncated if 3 or more consecutive
ambiguous bases , ‘Ns’, are detected to eliminate queries
with poor sequence quality. (4) If the query is less than
30 bp it is eliminated, since it will be below the alignment
score cutoff (see section ‘Align query sequences to the
genome and filter alignments’ for details). Only sequence
reads that contain an LTR-chromosome junction and re-
sult in a query that is at least 30 bp are considered for
alignment. Searching for a LC sequence is optional to
maximize the flexibility of VISA.
Align query sequences to the genome and filter
alignments
Query sequences are aligned to the Genome Reference
Consortium Human Build 38 (hg38) and the selected
vector sequence using BLAT [8]. BLAT is used with the
following parameters: blat.exe chromosome_file query_
file -out = blast8 -tileSize = 11 -stepSize = 5 -ooc = 11-
2253.ooc output_file (see Additional file 1 for details
about the generation of the ooc file). Users have the op-
tion of processing sequence reads without using the ooc
file as well. Alignments with an alignment score < 60, a
percent identity < 92 %, and/or that start more than 3 bp
from the query start site are no longer considered for
processing. For the remaining alignments, the 5 greatest
scoring alignments of each query sequence are retained
for further processing. These initial filtering steps are
done using a MySQL database on a separate server, re-
ducing the amount of memory needed by the application
server to process each input file.
Additional filtering criteria are applied to the greatest
scoring alignments of each query sequence to eliminate
RISs that cannot be unequivocally aligned to the gen-
ome. The filters, applied in order, are as follows:
(1) The greatest scoring alignment is to the vector
sequence.
(2) The second greatest scoring alignment has an
alignment score > 95 % than that of the greatest
scoring alignment. For lower scoring alignments,
alignment scores < 100, this is reduced to 90 %.
(3) The greatest scoring alignment has a percent
identity < 95 %.
For query sequences that exceed the elimination cri-
teria in quality and confidence, it is assumed that the
greatest scoring alignment is the RIS for the associated
sequence read and is labeled a ‘candidate RIS’. Query se-
quences that do not meet the criteria are filtered out
and reported separately from the candidate RISs in the
results.
Identify unique retroviral vector integration sites
There can be repeated recovery of a specific RIS due to
PCR amplification bias or legitimate clonal expansion
after integration. Also, sequencing errors can lead to
mapping of the same RIS within a few bp of the actual
integration site. Both of these potential scenarios are
handled by assuming candidate RISs within ±5 bp of the
same chromosome location represent the same RIS.
Candidate RISs are binned and sorted by chromosome
locations. Then, within each 10 bp window (±5 bp) the
candidate RIS with the greatest alignment score is
assigned as the unique RIS. Candidate RISs that align to
the same chromosome location as a unique RIS are la-
beled ‘repeat RIS’ and those that align within the 10 bp
window of a unique RIS are labeled ‘in range RIS’. The
frequency and the number of distinct bp spans of each
unique RIS is reported (see Additional file 1 section
‘Identifying unique retroviral vector integration sites’ for
an example and a discussion of the 10 bp window for
grouping candidate RISs).
Determine proximity of unique retroviral vector
integration sites to nearby genes
Unique RISs can also be further processed to determine
their proximity to nearby genes using RefSeq gene anno-
tations and a user-provided list of genomic features.
Large scale integration analyses have shown that differ-
ent types of retroviral vectors have distinct integration
profiles, e.g., lentiviral vectors have a strong preference
to integrate within genes [9] whereas foamy viral vectors
have a modest preference for transcription start sites
[10]. Also, the position of the provirus relative to a gene
may influence the mechanism by which the provirus can
potentially dysregulate the gene. For example, enhancer
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activation may occur when integration occurs upstream
of the gene and premature polyadenylation may occur
when integration occurs within a gene. For these rea-
sons, VISA determines the proximity of RISs to genes in
2 distinct phases: (1) VISA determines if a unique RIS is
within a gene. If the unique RIS is not within a gene, its
distance to the nearest gene, up to 5 kb away from either
the 5′ end or the 3′ end, is determined. (2) Then VISA
determines the distance of the unique RIS to the nearest
transcription start site of a gene. It is possible for a pro-
virus to be within a particular gene, but actually be in
closer proximity to the transcription start site of another
gene. Other relevant information, such as the percent of
unique RISs within genes and the number of unique
RISs within 5 kb of genes, is also reported. When deter-
mining the proximity of RISs to user-provided genomic
features, VISA determines if each RIS is within a specific
genomic feature or its distance to the closest genomic
feature (see Additional file 1 section ‘Determining the
proximity of unique RISs to a user-provided list of gen-
omic features’ for the requirements of the genomic fea-
ture list). Pearson's chi-squared goodness of fit test is
used to determine the significance of these results. The
proximity of 100,000 randomly generated integration
sites to the set of RefSeq genes and custom genomic fea-
tures are used as the expected values in the Pearson chi-
squared goodness of fit analyses.
Generate random integration sites
VISA can also generate random integration datasets for
use as a control. Randomly selected sites are extracted
from the hg38 chromosome sequences. Users can specify
random site lengths from 30 to 1000 bp and the number
of random sites from 1 to 100,000. Randomly generated
sites are then processed the same as datasets generated
by NGS to impart the same biases that occur from align-
ment to hg38.
Results and discussion
VISA processes sequence reads and identifies unique
RISs without adding a substantial amount of time after
the alignment process (Fig. 1). Memory efficiency is
largely accomplished by employing a MySQL database
for the initial alignment filtering. This strategy reduces
the strain on the server resources while processing large
NGS datasets in parallel. Binning the candidate RISs into
10 bp windows and then designating the unique RISs
based on the alignment scores is a time efficient method
to identify unique RISs. The compromise between time
and memory efficiency allows VISA to be scalable with
NGS (Fig. 2).
VISA allows investigators to analyze NGS data for
RISs from human cell and tissue samples without the
need to develop custom scripts. Using VISA provides a
consistent method to analyze the integration profiles of
retroviral vectors for preclinical and clinical studies. The
frequency and span count of unique RISs and the prox-
imity of unique RISs to genes can provide insight into
both the genotoxicity of vectors and the clonality of the
transduced cells. Selecting the unique RISs based on the
alignment scores ensures that the sequence read with
the best alignment represents each RIS. VISA has two
important advantages over previously reported RIS tools
[11–14]; reporting the span count in conjunction with
the frequency of unique RISs, which provides a means
of quality control when analyzing the clonality of
Figure 1 VISA requires minimal processing time relative to the
alignment process. The processing steps are as follows: (1) Identify
LTR-chromosome junctions and generate query sequences, (2) align
query sequences to the genome using BLAT, (3) retrieve the top 5
alignments for each query sequence and filter out alignments that
cannot be aligned to a unique location in the genome, (4) identify
the unique RISs, (5) determine proximity of unique RISs to nearby
genes, and (6) prepare the excel and CSV output files. Sequence reads
containing lentiviral LTR-chromosome junctions were processed with
VISA. 3 input files were used with a mean of 502,083 sequence reads
per file. Standard error bars are shown. * indicates the value is less than
1 %
Figure 2 VISA is scalable with NGS. Several factors affect the amount
of processing time required for an input file, including the number of
reads that can be mapped to the genome and the number of files
being processed in parallel. Each input file was processed 3 times.
Standard error bars are shown
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transduced cells with certain PCR based methods [7],
and the ability to generate random RIS datasets, that
have the same biases in localization to hg38, as control
datasets. VISA also is extremely flexible. The only re-
quirement to use VISA is that the uploaded sequence file
is in the FASTA format and that the appropriate vector
and LTR sequence has been provided or selected via the
dropdown menu. Also, the parameters discussed above
used to filter the alignments and to identify unique RISs
are the default and recommended settings, but these can
be changed by users who find other criteria more appro-
priate. This flexibility means VISA can be used to
analyze data from various NGS methods. VISA provides
a concise and a complete version of the results from
processed sequence reads. The concise version of the re-
sults contains the unique RISs and emphasizes pertinent
information, such as the frequency and span counts, the
alignment scores, and the proximity of unique RISs to
RefSeq genes. For investigators who would like to look
into why certain sequence reads did not contain a
unique RIS, the complete version of the results contains
the filtered alignments in separate Excel sheets. All results
are provided in a tabular format as an Excel document or
as compressed CSV files through a private and secure link
once processing is complete. Finally, data can be distrib-
uted to users via their email, but VISA also allows an-
onymous usage. Example input and output files and other
helpful links can be found on the VISA homepage [15].
Conclusions
VISA is a time and memory efficient web-based tool that
allows investigators to analyze large NGS datasets for
RISs in a consistent manner. Results are returned in a
simple format to allow rapid analysis of the integration
profile and genotoxicity of retroviral vectors and map-
ping of RIS for retroviral mutagenesis screens.
Availability and requirements
Project name: VISA (Vector Integration Site Analysis)
Project home page: https://visa.pharmacy.wsu.edu/
bioinformatics/
Operating systems: Platform independent
Programming language: Perl, MySQL
Other requirements: Firefox, Chrome, IE, or Safari.
JavaScript must be enabled.
License: None
Any restrictions to use by non-academics: VISA can-
not be used for commercial use.
Additional file
Additional file 1: Supplementary methods, results, figures, and
examples.
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